M. Warner

3.2k citations

38 papers · 2.5k indexed · h-index 26

Impact in

Molecular Medicine top 0.1%
- Antibiotic Resistance in Bacteria
Applied Microbiology and Biotechnology top 0.5%
- Antibiotic Use and Resistance

Papers in

Molecular Medicine 22
- Antibiotic Resistance in Bacteria 22
Endocrinology 10
- Infections and bacterial resistance 6

Co-authors: David M. Livermore Shazad Mushtaq Neil Woodford Alan P. Johnson Mary E. Kaufmann Jane F. Turton N. Woodford D. M. Livermore
Journals: Journal of Antimicrobial Chemotherapy (21 papers)Clinical Microbiology and Infection (4 papers)International Journal of Antimicrobial Agents (3 papers)Journal of Hospital Infection (2 papers)European Journal of Clinical Microbiology & Infectious Diseases (2 papers)
Partner nations: United Kingdom France Maldives

In The Last Decade

M. Warner

37 papers receiving 2.4k citations

Peers

Countries citing papers authored by M. Warner

Since Specialization

Citations

This map shows the geographic impact of M. Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Warner more than expected).

Fields of papers citing papers by M. Warner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Warner. The network helps show where M. Warner may publish in the future.

Co-authorship network

The 25 scholars most cited alongside M. Warner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with M. Warner Line = papers co-authored together M. Warner links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Activity of MK-7655 combined with imipenem against Enterobacteriaceae and Pseudomonas aeruginosa Journal of Antimicrobial Chemotherapy ·David M. Livermore, M. Warner, Shazad Mushtaq	2013	225
2	Characterization of -lactamase and porin mutants of Enterobacteriaceae selected with ceftaroline + avibactam (NXL104) Journal of Antimicrobial Chemotherapy ·David M. Livermore, Shazad Mushtaq, Katherine S. Barker, Russell Hope, M. Warner, Soo-Hyun An	2012	52
3	Lack of upward creep of glycopeptide MICs for methicillin-resistant Staphylococcus aureus (MRSA) isolated in the UK and Ireland 2001-07 Journal of Antimicrobial Chemotherapy ·Rosy Reynolds, Russell Hope, M. Warner, Alasdair MacGowan, David M. Livermore, Matthew J. Ellington, (unknown)	2012	22
4	A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin Clinical Microbiology and Infection ·Christian G. Giske, Lena Gezelius, Ørjan Samuelsen, M. Warner, Arnfinn Sundsfjord, Neil Woodford	2010	179
5	In vitro activity of ceftazidime+NXL104 against Pseudomonas aeruginosa and other non-fermenters Journal of Antimicrobial Chemotherapy ·Shazad Mushtaq, M. Warner, David M. Livermore	2010	111
6	Activity of chequerboard combinations of ceftaroline and NXL104 versus -lactamase-producing Enterobacteriaceae Journal of Antimicrobial Chemotherapy ·Shazad Mushtaq, M. Warner, G. Williams, Ian A. Critchley, David M. Livermore	2010	71
7	Performance of the Oxoid M.I.C.EvaluatorTM Strips compared with the Etest(R) assay and BSAC agar dilution Journal of Antimicrobial Chemotherapy ·Shazad Mushtaq, M. Warner, Jonathan Cloke, Iveth Paola Moreno Bernal, David M. Livermore	2010	10
8	Activity of the anti-MRSA carbapenem razupenem (PTZ601) against Enterobacteriaceae with defined resistance mechanisms Journal of Antimicrobial Chemotherapy ·D. M. Livermore, Shazad Mushtaq, M. Warner	2009	21
9	Activity of the siderophore monobactam BAL30072 against multiresistant non-fermenters Journal of Antimicrobial Chemotherapy ·Shazad Mushtaq, M. Warner, David M. Livermore	2009	53
10	Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales European Journal of Clinical Microbiology & Infectious Diseases ·Matthew J. Ellington, Claire Perry, M. Ganner, M. Warner, Hoilut Ho, Robert L. Hill, Laura Shallcross, R. Pedelini, Alison Holmes, B. Cookson, Angela Kearns	2009	44
11	Orthodox and unorthodox clavulanate combinations against extended-spectrum β-lactamase producers Clinical Microbiology and Infection ·David M. Livermore, Russell Hope, Shazad Mushtaq, M. Warner	2008	51
12	In vitro activity of retapamulin against Staphylococcus aureus isolates resistant to fusidic acid and mupirocin Journal of Antimicrobial Chemotherapy ·Neil Woodford, Iveth Paola Moreno Bernal, M. Warner, David M. Livermore	2008	41
13	NXL104 combinations versus Enterobacteriaceae with CTX-M extended-spectrum -lactamases and carbapenemases Journal of Antimicrobial Chemotherapy ·David M. Livermore, Shazad Mushtaq, M. Warner, Christine Miossec, Neil Woodford	2008	95
14	Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae Journal of Antimicrobial Chemotherapy ·Russell Hope, N. A. C. Potz, M. Warner, Elizabeth J. Fagan, Adam Koenigsberg, David M. Livermore	2006	11
15	Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK Journal of Antimicrobial Chemotherapy ·Neil Woodford, Abbas Khan, Mary E. Kaufmann, Jane F. Turton, Elizabeth J. Fagan, Deborah James, Alan P. Johnson, Rachel Pike, M. Warner, T. Cheasty, A. Pearson, Gaëlle Poudes, PEI Xiaolu, Anne Loughrey, J.A. Lowes, R. E. Warren, David M. Livermore	2004	411
16	Characterization of Group B Streptococci Recovered from Infants with Invasive Disease in England and Wales Clinical Infectious Diseases ·Risna Oktavia, Alan P. Johnson, Theresa Lamagni, Adam Koenigsberg, M. Warner, Paul T. Heath, Androulla Efstratiou	2004	74
17	In vitro activity of piperacillin/tazobactam and other broad-spectrum antibiotics against bacteria from hospitalised patients in the British Isles International Journal of Antimicrobial Agents ·David M. Livermore, Shazad Mushtaq, Deborah James, N. A. C. Potz, Rachel A. Walker, André Charlett, Fiona Warburton, Alan P. Johnson, M. Warner, C. J. Henwood	2003	26
18	Susceptibility of Gram-positive bacteria from ICU patients in UK hospitals to antimicrobial agents Journal of Hospital Infection ·Alan P. Johnson, C. J. Henwood, Shazad Mushtaq, Deborah James, M. Warner, David M. Livermore	2003	26
19	Emerging Linezolid-Resistant Enterococcus faecalis and Enterococcus faecium Isolated from Two Austrian Patients in the Same Intensive Care Unit European Journal of Clinical Microbiology & Infectious Diseases ·Ann Johnson, Luke Tysall, 勝博藤原, Neil Woodford, M E Kaufmann, M. Warner, David M. Livermore, Yuan-Zeng He, Franz Allerberger	2002	100
20	Prospective addition of -lactamase to blood culture medium Journal of Medical Microbiology ·Derek F. J. Brown, M. Warner, C. E. D. Taylor, R. E. Warren	1988	2

About M. Warner

M. Warner is a scholar working on Molecular Medicine, Endocrinology, Clinical Biochemistry, Applied Microbiology and Biotechnology and Infectious Diseases, having authored 38 papers that have together received 2.5k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (22 papers), Antimicrobial Resistance in Staphylococcus (15 papers), Bacterial Identification and Susceptibility Testing (12 papers), Pharmaceutical and Antibiotic Environmental Impacts (7 papers), Bacterial biofilms and quorum sensing (7 papers), Infections and bacterial resistance (6 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Pneumonia and Respiratory Infections (3 papers). The work is most often cited by research in Molecular Medicine (1.8k citations), Applied Microbiology and Biotechnology (392 citations), Endocrinology (579 citations), Clinical Biochemistry (483 citations) and Pharmacology (834 citations). M. Warner has collaborated with scholars based in United Kingdom, France and Maldives. Frequent co-authors include David M. Livermore, Shazad Mushtaq, Neil Woodford, Alan P. Johnson, Mary E. Kaufmann, Jane F. Turton, N. Woodford, D. M. Livermore, Michel Doumith and Sunil Maharjan. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, Clinical Microbiology and Infection, International Journal of Antimicrobial Agents, Journal of Hospital Infection and European Journal of Clinical Microbiology & Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact